Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 66, Issue 7, Pages 1417-1430
Publisher
Oxford University Press (OUP)
Online
2011-05-10
DOI
10.1093/jac/dkr173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Susceptibility of ClinicalMycobacterium tuberculosisIsolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
- (2011) J. W. C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis
- (2011) A. Engstrom et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones
- (2010) M. R. Pasca et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thr202Ala in thyA Is a Marker for the Latin American Mediterranean Lineage of the Mycobacterium tuberculosis Complex Rather than Para-Aminosalicylic Acid Resistance
- (2010) S. Feuerriegel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs
- (2010) K.L. Leung et al. JOURNAL OF APPLIED MICROBIOLOGY
- Mutations in Extensively Drug‐ResistantMycobacterium tuberculosisThat Do Not Code for Known Drug‐Resistance Mechanisms
- (2010) Alifiya S. Motiwala et al. JOURNAL OF INFECTIOUS DISEASES
- Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance
- (2010) Giulia Manina et al. MOLECULAR MICROBIOLOGY
- A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine
- (2010) Noton K. Dutta et al. PLoS One
- Mycobacterial Subversion of Chemotherapeutic Reagents and Host Defense Tactics: Challenges in Tuberculosis Drug Development
- (2009) Liem Nguyen et al. Annual Review of Pharmacology and Toxicology
- High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
- (2009) L. Jugheli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
- (2009) A. M. Ginsberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Genetics of para-Aminosalicylic Acid Resistance in Clinical Isolates and Spontaneous Mutants of Mycobacterium tuberculosis
- (2009) V. Mathys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
- (2009) A. Von Groll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America
- (2009) Elis R Dalla Costa et al. BMC MICROBIOLOGY
- Fitness study of the RDRiolineage and Latin AmericanâMediterranean family ofMycobacterium tuberculosisin the city of Rio Grande, Brazil
- (2009) Andrea Von Groll et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
- (2009) Abigail Wright et al. LANCET
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis
- (2009) M. A. Zaunbrecher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Tuberculosis ethambutol resistance: Concordance between phenotypic and genotypic test results
- (2009) Claudia Plinke et al. TUBERCULOSIS
- Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin
- (2008) H. Safi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism
- (2008) F. S. Spies et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Porins for Uptake of Antibiotics by Mycobacterium smegmatis
- (2008) O. Danilchanka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis
- (2008) P. Jureen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Arylamine N-Acetyltransferases in Mycobacteria
- (2008) Edith Sim et al. CURRENT DRUG METABOLISM
- New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
- (2008) Emma C. Rivers et al. DRUG DISCOVERY TODAY
- Arylamine N-acetyltransferases: From Structure to Function
- (2008) Edith Sim et al. DRUG METABOLISM REVIEWS
- Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities
- (2008) Marta Martins et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates
- (2008) Zhaogang Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rv1698 ofMycobacterium tuberculosisRepresents a New Class of Channel-forming Outer Membrane Proteins
- (2008) Axel Siroy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rifampin Resistance, Beijing-W Clade-Single Nucleotide Polymorphism Cluster Group 2 Phylogeny, and the Rv2629 191-C Allele in Mycobacterium tuberculosis Strains
- (2008) S. Chakravorty et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636
- (2008) V. Bhowruth et al. MICROBIOLOGY-SGM
- Mycothiol biosynthesis is essential for ethionamide susceptibility inMycobacterium tuberculosis
- (2008) Catherine Vilchèze et al. MOLECULAR MICROBIOLOGY
- Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
- (2008) Christopher Dye NATURE REVIEWS MICROBIOLOGY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Identification of outer membrane proteins of Mycobacterium tuberculosis
- (2008) Houhui Song et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started